H. Ballentine Carter

African American Men With Very Low–Risk Prostate Cancer Exhibit Adverse Oncologic Outcomes After Radical Prostatectomy: Should Active Surveillance Still Be an Option for Them?

Debasish Sundi, Ashley E. Ross, Elizabeth B. Humphreys et al. · Journal of Clinical Oncology · 2013 · 233 citations · Full text

Serum Levels of Insulin-Like Growth Factor I (IGF-I), IGF-II, IGF-Binding Protein-3, and Prostate-Specific Antigen as Predictors of Clinical Prostate Cancer

S. Mitchell Harman, E. Jeffrey Metter, Marc R. Blackman et al. · The Journal of Clinical Endocrinology & Metabolism · 2000 · 218 citations · Full text

Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies

William G. Nelson, Jonathan W. Simons, Bahar Mikhak et al. · Cancer Chemotherapy and Pharmacology · 2000 · 78 citations

Cancer Immunosurveillance, Granulocyte, Medicine +9

Variability in Medicare Utilization and Payment Among Urologists

Joan Ko, Heather J. Chalfin, Bruce J. Trock et al. · Urology · 2015 · 44 citations

Urology, Health Economics, Health Policy +6

Spinal Anesthesia Does Not Impact Prostate Cancer Recurrence in a Cohort of Men Undergoing Radical Prostatectomy

Kenneth S. Tseng, Sachin Narayan Kulkarni, Elizabeth B. Humphreys et al. · Regional Anesthesia & Pain Medicine · 2014 · 39 citations · Full text